Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes

Journal of Heart and Lung Transplantation

Volumn 29, Issue 5, 2010, Pages 504-508

  Kobashigawa, Jon A ^a   Kiyosaki, Krista K ^a   Patel, Jignesh K ^a   Kittleson, Michelle M ^a   Kubak, Bernard M ^a   Davis, Stephanie N ^a   Kawano, Matt A ^a   Ardehali, Abbas A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

heart transplantation; immune monitoring; infection; outcomes; rejection

Indexed keywords

ADENOSINE TRIPHOSPHATE; CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HEART HEMODYNAMICS; HEART TRANSPLANTATION; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SCORING SYSTEM; STEADY STATE;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; DRUG THERAPY, COMBINATION; ENDOCARDIUM; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MONITORING, IMMUNOLOGIC; MYCOPHENOLIC ACID; MYOCARDIUM; OPPORTUNISTIC INFECTIONS; PREDNISOLONE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TACROLIMUS;

EID: 77950518617     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.12.015     Document Type: Article

References (10)

1. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
2. Jusko W.J., Thomson A.W., Fung J., et al. Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit 17 (1995) 606-614
3. Kowalski R., Post D., Schneider M.C., et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17 (2003) 77-88
4. Kowalski R.J., Post D.R., Mannon R.B., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation 82 (2006) 663-668
5. Rodrigo E., and Arias M. A practical approach to immune monitoring in kidney transplantation. Minerva Urol Nefrol 59 (2007) 337-352
6. Cadillo-Chavez R., Echegaray S., Santiago-Delpin E.A., et al. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay. Transplant Proc 38 (2006) 918-920
7. Thai N.L., Blisard D., Tom K., et al. Pancreas transplantation under alemtuzumab (Campath-1H) and tacrolimus: correlation between low T-cell responses and infection. Transplantation 82 (2006) 1649-1652
8. Zeevi A., Britz J.A., Bentlejewski C.A., et al. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transplant Immunol 15 (2005) 17-24
9. Gupta S., Mitchell J.D., Markham D.W., et al. Utility of the Cylex assay in cardiac transplant recipients. J Heart Lung Transplant 27 (2008) 817-822
10. Lee T.C., Goss J.A., Rooney C.M., et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 20 (2006) 689-694